Fundz

Cellbricks Therapeutics secures €10M in Seed funding led by Silicon Roundabout Ventures to advance biofabricated human tissue implants.

PRIVATEMar 26, 2026

Amount Raised

€7 Million

Round Type

Seed

ManufacturingBiotechnologyHealth CareTherapeutics

Investors

Germany’s Federal Agency For Breakthrough Innovation (Sprind)ACT Venture PartnersSilicon Roundabout Ventures

Description

Cellbricks Therapeutics, based in Berlin and Boston, has raised approximately €10M in funding, consisting of a €7M Seed round. The investment was led by Silicon Roundabout Ventures and includes contributions from various investors. The funds will support the next stage of development for their biofabricated human tissue implants. Co-CEOs Alexander Leutner and Dr

Who else raised in Therapeutics and Manufacturing around the same time

Companies in the same sectors as Cellbricks Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $3.4M on April 27, 2026.
  • Remedium Bio raised $10M (Series A) on May 6, 2026.
  • Citius Oncology raised $37M on May 6, 2026.
  • CellCentric raised $220M (Series D) on May 6, 2026.
  • Windward Bio raised $165M (Funding Round) on May 5, 2026.
  • Aura Biosciences, Inc. raised $238M (Post-IPO Equity) on May 4, 2026.

Who to call at Cellbricks Therapeutics, and when

A new round usually means Cellbricks Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cellbricks Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cellbricks Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cellbricks Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cellbricks Therapeutics

About

Cellbricks Therapeutics is a tissue engineering company developing biofabricated human tissue implants for regenerative medicine. Using a proprietary biofabrication platform, it engineers vascularized human tissue therapeutics designed to restore function in patients suffering from severe tissue damage. The company aims to address complex wounds and soft tissue defects, with long-term applications in organ repair and replacement.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cellbricks Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlexander L., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cellbricks Therapeutics's next move

See what Strategic adds

Cellbricks Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.